IL21R and neoplasm: The transferred cells and TCR+ cells percentage in the bone marrow and spleen 7 days after transfer was comparable in mice receiving TCR-T and IL-21R-TCR-T (Supplementary Fig. 9c, d), indicating that the powerful infiltrating capacity of IL-21R-TCR-T depends on the presence of tumor antigen.